Evaluating the Renal Safety of Investigational New Drugs: Where Should We Be Going?

2017 ◽  
Vol 102 (3) ◽  
pp. 387-388 ◽  
Author(s):  
N Stockbridge ◽  
M Blank ◽  
EA Hausner ◽  
A Thompson
Keyword(s):  
New Drugs ◽  
Renal Safety ◽  
Investigational New Drugs

Investigational new drugs for the treatment of acute coronary syndrome

2015 ◽  
Vol 24 (12) ◽  
pp. 1557-1570 ◽  
Author(s):  
Cormac T O’Connor ◽  
Thomas J Kiernan ◽  
Bryan P Yan
Keyword(s):  
Acute Coronary Syndrome ◽  
New Drugs ◽  
Coronary Syndrome ◽  
Investigational New Drugs

scholarly journals Investigational new drugs for brain cancer

2016 ◽  
Vol 25 (8) ◽  
pp. 937-956 ◽  
Author(s):  
Verena Staedtke ◽  
Ren-Yuan Bai ◽  
John Laterra
Keyword(s):  
Brain Cancer ◽  
New Drugs ◽  
Investigational New Drugs

Investigational new drugs for the treatment of resistant pneumococcal infections

2005 ◽  
Vol 14 (8) ◽  
pp. 973-995 ◽  
Author(s):  
Holly L Hoffman-Roberts ◽  
Emily C Babcock ◽  
Isaac F Mitropoulos
Keyword(s):  
New Drugs ◽  
Pneumococcal Infections ◽  
Investigational New Drugs

scholarly journals Relationship between objective responses in phase I trialsand potential efficacy of non-specific cytotoxic investigational new drugs

2002 ◽  
Vol 13 (8) ◽  
pp. 1300-1306 ◽  
Author(s):  
I. Sekine ◽  
N. Yamamoto ◽  
H. Kunitoh ◽  
Y. Ohe ◽  
T. Tamura ◽  
...  
Keyword(s):  
Phase I ◽  
New Drugs ◽  
Potential Efficacy ◽  
Investigational New Drugs
Sign in / Sign up

Export Citation Format

Share Document